Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
Phase 1 Terminated
37 enrolled
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
Phase 1 Terminated
12 enrolled
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
Phase 1 Terminated
157 enrolled
Clinical Trial of WBC100 on Advanced Solid Tumor
Phase 1 Terminated
68 enrolled
Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours
Phase 1 Terminated
3 enrolled
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
Phase 1 Terminated
13 enrolled
MESO-PRIME
Phase 1 Terminated
5 enrolled 13 charts
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
Phase 1 Terminated
1 enrolled
HV-101 for Patients With Advanced Solid Tumors
Phase 1 Terminated
1 enrolled
TIL for Patients With Advanced Solid Tumor
Phase 1 Terminated
5 enrolled
STARMAP
Phase 1 Terminated
19 enrolled
POLAR
Phase 1 Terminated
26 enrolled 14 charts
A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Phase 1 Terminated
128 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Terminated
12 enrolled
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
Phase 1 Terminated
3 enrolled
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
Phase 1 Terminated
76 enrolled
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors
Phase 1 Terminated
67 enrolled 22 charts
MINOTAUR
Phase 1 Terminated
38 enrolled 17 charts
LIONS (PLK4 Inhibitor in Advanced Solid Tumors)
Phase 1 Terminated
29 enrolled 15 charts
A Study of BRY805 in Participants With Advanced Solid Tumors
Phase 1 Terminated
13 enrolled
A Study of LY3405105 in Participants With Advanced Cancer
Phase 1 Terminated
54 enrolled 26 charts
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
Phase 1 Terminated
62 enrolled 25 charts
A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors
Phase 1 Terminated
34 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Phase 1 Terminated
83 enrolled
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
3 enrolled 19 charts
Phase I Study of RiMO-401 With Radiation in Advanced Tumors
Phase 1 Terminated
5 enrolled
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors
Phase 1 Terminated
45 enrolled
Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors
Phase 1 Terminated
109 enrolled
A Study of DS-1471a In Subjects With Advanced Solid Tumors
Phase 1 Terminated
17 enrolled
Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients
Phase 1 Terminated
13 enrolled
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors
Phase 1 Terminated
83 enrolled
The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer
Phase 1 Terminated
23 enrolled
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
Phase 1 Terminated
40 enrolled
Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)
Phase 1 Terminated
25 enrolled
Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
Phase 1 Terminated
25 enrolled
A Study of TAK-102 in Adult With Previously-Treated Solid Tumors
Phase 1 Terminated
12 enrolled
A Study of TAK-103 in Adult With Solid Tumors
Phase 1 Terminated
2 enrolled
Study of NIB101 in Participants With Advanced Solid Tumors
Phase 1 Terminated
3 enrolled
A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Phase 1 Terminated
49 enrolled 31 charts
Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors
Phase 1 Terminated
55 enrolled
RAPTOR
Phase 1 Terminated
27 enrolled
Evaluate Eribulin ORA in Subjects With Solid Tumors
Phase 1 Terminated
10 enrolled
Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Phase 1 Terminated
106 enrolled
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Phase 1 Terminated
46 enrolled
A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors
Phase 1 Terminated
46 enrolled
FPT155-001
Phase 1 Terminated
80 enrolled 49 charts
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Phase 1 Terminated
54 enrolled 42 charts